Evidence map›Paper›PMID 40585380›Full record

ArticleGynecologic oncology reports2025

Fertility preserving, uterine sparing approach to a uterine extragonadal yolk sac tumor.

Michelle Greenman, Blair McNamara, Victoria Ettorre, Natalia Buza, Masoud Azodi

Abstract readCase Reports
In one paragraph

Article in Gynecologic oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michelle GreenmanDepartment of Obstetrics, Gynecology, and Reproductive Sciences, Yale University, School of Medicine, New Haven, CT, USA.
Blair McNamaraDepartment of Obstetrics, Gynecology, and Reproductive Sciences, Yale University, School of Medicine, New Haven, CT, USA.
Victoria EttorreDepartment of Obstetrics, Gynecology, and Reproductive Sciences, Yale University, School of Medicine, New Haven, CT, USA.
Natalia BuzaDepartment of Pathology, Yale University, School of Medicine, New Haven, CT, USA.
Masoud AzodiDepartment of Obstetrics, Gynecology, and Reproductive Sciences, Yale University, School of Medicine, New Haven, CT, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Treatment of a uterine extragonadal yolk sac tumor (EGYST) typically requires hysterectomy. Fertility preserving strategies are essential for young women who have not yet met their reproductive goals. Here we explore an option for uterine preservation. Methods: A 30-year-old presented with what was thought to be a degenerating fibroid but ultimately was diagnosed as an extragonadal yolk sac tumor. The myometrium and endometrium adjacent to the tumor were resected with negative margins, the uterus was reconstructed, and a fertility preserving staging procedure was performed followed by chemotherapy with bleomycin, etoposide, and cisplatin. She had a single recurrence which was surgically managed. Results: The patient has had no evidence of disease for the past six years since the recurrence was diagnosed. The patient has since spontaneously conceived pregnancy. Conclusion: This case successfully presents a surgical approach to managing a uterine extragonadal yolk sac tumor in a young woman that desired future fertility. A uterine wedge resection and reconstruction was able to adequately resect the tumor. This represents a treatment option for uterine preservation in women that have not yet completed childbearing.

Indexed as

Extragonadal yolk sac tumorFertility preservationGerm cell tumor

Identifiers

PMID40585380
PMCPMC12205314

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.